Pacira | PCRX - PE Price to Earnings


Pacira reported 52.68 in PE Price to Earnings for its fiscal quarter ending in December of 2025.





Pe Change Date
Astellas Pharma 15.48 8.16 Mar/2026
Bristol-Myers Squibb 9.28 1.04 Dec/2025
Cara Therapeutics 27.77 117.09 Sep/2021
Ironwood Pharmaceuticals 204.24 88.19 Dec/2024
J&J 24.53 0.91 Mar/2026
Ligand Pharmaceuticals 60.65 17.62 Sep/2025
Novo Nordisk 12.78 0.01 Dec/2025
Pacira 52.68 23.44 Dec/2025
Perrigo 58.96 24.65 Dec/2025
Pfizer 14.48 5.18 Dec/2025
Supernus Pharmaceuticals 110.38 71.27 Dec/2025
Teva Pharmaceutical Industries 10.11 1.04 Dec/2025
Xoma 52.12 3.09 Sep/2022
Zoetis 20.42 2.84 Dec/2025